Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression
NCT: NCT03191058 · COMPLETED
Brief Summary
This trial aims to assess the efficacy and tolerability of Magnetic Seizure Therapy (MST) as an alternative to electroconvulsive therapy (ECT) for depression. Even with multiple medication trials, 30 - 40% of patients will experience a pharmacologically resistant form of illness. The ineffectiveness of current treatments for major depressive disorder (MDD) coupled with the economic burden associated with the disorder engenders a need for novel therapeutic interventions that can provide greater response and remission rates.
Frequently Asked Questions
What is Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression?
Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression is a clinical trial registered under NCT03191058. Current status: COMPLETED.
What is the status of NCT03191058?
The current status of NCT03191058 (Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression) is: COMPLETED.
When did Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression start?
Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression started on 2018-06-26.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.